CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Charlotte, North Carolina, United States and 107 other locations
recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD) and preliminary antitumor activity of ORIC-944 in patients with metastatic prostate...
Phase 1
Charlotte, North Carolina, United States and 5 other locations
of enzalutamide in the treatment of subjects with metastatic prostate cancer. The purpose of this study is to assess if ADT + docet...
Phase 2
Charlotte, North Carolina, United States
Prostate cancer has the second highest incidence rate and is the fifth leading cause of cancer-related deaths among men wo ...
Phase 1
Huntersville, North Carolina, United States of America and 5 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Charlotte, North Carolina, United States and 220 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Concord, North Carolina, United States and 388 other locations
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetax...
Phase 3
Monroe, North Carolina, United States and 62 other locations
This is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling tim...
Phase 3
Charlotte, North Carolina, United States and 68 other locations
The purpose of this study was to evaluate the efficacy of enzalutamide plus androgen deprivation therapy (ADT) as measured by radiographic progressio...
Phase 3
Charlotte, North Carolina, United States and 202 other locations
prednisone in treating patients with castration-resistant metastatic prostate cancer. Androgens can cause the growth of prostate...
Phase 3
Charlotte, North Carolina, United States and 538 other locations
Clinical trials
Research sites
Resources
Legal